Baillie Gifford - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,418
-43.9%
2,5100.0%0.00%
Q4 2022$7,881
-34.3%
2,5100.0%0.00%
Q3 2022$12,000
+20.0%
2,5100.0%0.00%
Q2 2022$10,0002,5100.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Rokos Capital Management LLP 3,026,210$9,154,2850.40%
Rhenman & Partners Asset Management AB 820,000$2,574,8000.27%
WASATCH ADVISORS LP 12,650,754$39,723,3680.27%
Long Focus Capital Management, LLC 1,072,000$3,366,0800.23%
Avidity Partners Management LP 2,748,300$8,629,6620.19%
KLK CAPITAL MANAGEMENT LLC 44,323$139,1740.19%
Lombard Odier Asset Management (Switzerland) SA 607,760$1,908,3660.15%
Acrisure Capital Management, LLC 31,673$99,4530.11%
GSA CAPITAL PARTNERS LLP 200,465$6290.08%
Virtus ETF Advisers LLC 40,600$127,4840.07%
View complete list of SANGAMO THERAPEUTICS INC shareholders